Urgent.News

What's breaking now, across thousands of outlets.

Health & Medicine

DHA CEO Explains Referral System Amid SHA Outpatient Access Concerns

NAIROBI, Kenya, October 12 – The Digital Health Agency (DHA) is striving to link hospitals, health insurers, patients and medicine suppliers via digital platforms, aiming to enhance medical record sharing, safeguard patient data and diminish administrative delays. DHA Chief Executive Officer Anthony Lenayara discussed this during a Capital In The Morning interview, addressing concerns about outpatient access through Social Health Authority (SHA) amid criticisms from Nairobi County Chief Officer Geoffrey Mosiria.

Lenayara affirmed SHA's ongoing function and clarified the distinction between SHA's role in social health insurance management and the DHA's responsibility for digital health infrastructure. The agency, established under the Digital Health Act 2023, safeguards sensitive health data, ensures seamless information exchange, and standardises digital processes to boost healthcare accessibility.

Lenayara emphasized that patients should transition between Level 2 to Level 4 facilities for routine outpatient care rather than directly accessing Level 5 or 6 hospitals for basic services. This approach seeks to avoid overcrowding in referral hospitals, ensuring critical cases receive timely attention.

Written by urgent.news from Capital FM Kenya's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.

Read the original at capitalfm.africa →

More in Health & Medicine

Nigeria: Fidelis Ayebae's Fidson Takes Nigeria's Healthcare Story Global

[This Day] Fidson Healthcare Plc has been selected to develop and manufacture a generic version of Roche's influenza antiviral drug, baloxavir marboxil, through a licensing arrangement backed by the Medicines Patent Pool. The deal places founder Fidelis Ayebae's company among a small group of global manufacturers chosen for the programme.

  • Fidson Healthcare Plc develops generic baloxavir marboxil for Roche
  • Fidelis Ayebae, founder, has non-traditional engineering-business background
  • Fidson becomes first Nigerian pharma to exceed N119 billion in revenue

More from Monday 12 October →